Osteoporosis and Impetigo

Summary:

Impetigo is found among people with Osteoporosis, especially for people who are female, 60+ old.

The study analyzes which people have Impetigo with Osteoporosis. It is created by eHealthMe based on reports of 50 people who have Osteoporosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Osteoporosis?

Osteoporosis (bones weak and more likely to break) is found to be associated with 1,811 drugs and 1,900 conditions by eHealthMe. Check the latest studies of Osteoporosis.

What is Impetigo?

Impetigo (contagious skin infection) is found to be associated with 331 drugs and 449 conditions by eHealthMe. Check the latest studies of Impetigo.

On Jul, 13, 2026

50 people who have Osteoporosis and Impetigo are studied.

Would you have Impetigo when you have Osteoporosis?

Gender of people who have Osteoporosis and experienced Impetigo *:

female: 89.8 %
male: 10.2 %

Age of people who have Osteoporosis and experienced Impetigo *:

Common co-existing conditions for these people *:

Skin Ulcer: 5 people, 10.00%
Iron Overload: 5 people, 10.00%
Neurosis (a class of functional mental disorders involving distress but neither delusions nor hallucinations): 5 people, 10.00%
Oral Herpes (viral infection of mouth): 5 people, 10.00%
High Blood Pressure: 4 people, 8.00%
Hypersensitivity: 4 people, 8.00%
Pain: 4 people, 8.00%
High Blood Cholesterol: 3 people, 6.00%
Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 6.00%
Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 4.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Stress And Anxiety: 32 people, 64.00%
Cellulitis (infection under the skin): 27 people, 54.00%
Fall: 26 people, 52.00%
Malaise (a feeling of general discomfort or uneasiness): 23 people, 46.00%
Head Injury: 22 people, 44.00%
Pain: 22 people, 44.00%
Back Pain: 22 people, 44.00%
Osteomyelitis (infection of bone): 21 people, 42.00%
Osteopenia (a condition where bone mineral density is lower than normal): 21 people, 42.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 20 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Impetigo?

- Check whether Impetigo is associated with a drug or a condition

Related publications that referenced our studies

Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .

Related studies:

Treatments, associated drugs and conditions:

Osteoporosis (290,734 reports)
Impetigo (2,385 reports)

All the drugs that are associated with Impetigo:

Impetigo (331 drugs)

All the conditions that are associated with Impetigo:

Impetigo (449 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Impetigo and Osteoporosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.